Fauci’s Promotional Hype Catapults Gilead’s Remdesivir
What if any, Scientific or Empirical Evidence Supports Use of Remdesivir as “Standard of Care”? Unlike other drugs being tested against the new coronavirus, remdesivir hasn’t received official approval for any use in normal conditions anywhere in the world against any illness. On April 29, 2020, Chinese remdesivir study was published in The Lancet , … Continue reading Fauci’s Promotional Hype Catapults Gilead’s Remdesivir
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed